Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2034224 | 0.84 | ALDH1A1 (0.42) | ALDH1A1MAPK1 | |
| SCHEMBL29019598 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| Lithium SCHEMBL30748652 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL29141961 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL25384999 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL25343357 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL31709613 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| Potassium SCHEMBL31463361 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL21194948 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 | |
| SCHEMBL30028129 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9452987-B2 | Five-membered cyclic anion use thereof as an electrolyte | CENTRE NAT RECH SCIENT (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20150315155-A1 | FIVE-MEMBERED CYCLIC ANION USE THEREOF AS AN ELECTROLYTE | CENTRE NAT RECH SCIENT (FR) | 2015-11-05 | — | — | US | disclosed |
| CN-104262259-A | Pentacyclic Anion Salt And Use Thereof As An Electrolyte | CENTRE NAT RECH SCIENT | 2015-01-07 | — | — | CN | disclosed |
| US-8927160-B2 | Pentacyclic anion salt and use thereof as an electrolyte | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-01-06 | — | — | US | disclosed |
| US-20110311884-A1 | PENTACYCLIC ANION SALT AND USE THEREOF AS AN ELECTROLYTE | UNIVERSITE DE PICARDIE JULES VERNE (FR) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311884-A1 | PENTACYCLIC ANION SALT AND USE THEREOF AS AN ELECTROLYTE | AFF1, SLCO4C1, F9 | ALDH1A1 2110/4885MAPK1 321/4885AR 2004/4885 |
| US-20150315155-A1 | FIVE-MEMBERED CYCLIC ANION USE THEREOF AS AN ELECTROLYTE | KCNA5, SLCO4C1, AFF1 | ALDH1A1 2092/4885MAPK1 927/4885AR 3051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.